Monthly Archives: November 2013

Featured Stories
Former Executives Accuse Health Technology Firm of Fraud

Former Executives Accuse Health Technology Firm of Fraud

Former NantHealth executives claim that the company made fraudulent claims about the reliability of its system, which links patient information gathered by the devices.

Read More

Pennsylvania Health System Proposes Comprehensive Fracking Study

A proposed study would examine the health effects of hydraulic fracturing (fracking) drilling on the people living closest to active natural gas wells.

Read More

New York Man Claims Biomet Metal-on-Metal Hip Implant Caused Pain, Disability

A New York man claims his metal-on-metal hip implant was defective and required replacement within a year of receiving it. This has left him facing a lifetime of pain, disability, and rising medical costs.

Read More

Tennessee Resident Files Pradaxa Bleeding Lawsuit Following Cerebral Hemorrhage

A man from Tennessee has filed a lawsuit against the maker of Pradaxa, claiming that the blood thinner caused him to suffer a cerebral hemorrhage. The complaint alleges Boehringer Ingelheim Pharmaceuticals, Inc. concealed knowledge that Pradaxa can cause Serious, life-threatening bleeds, and did not warn that Pradaxa bleeding side effects ...

Read More

Lawsuit Alleges Plavix Caused Oklahoma Man to Suffer Multiple Stomach Bleeds

Another lawsuit has been filed over adverse Plavix side effects. The lawsuit, filed by national law firm Parker Waichman LLP, alleges that the blood thinner, Plavix (clopidogrel), caused an Oklahoma man to suffer from multiple stomach bleeds.

Read More

MTA Bus Crash and Two Cars Injures 23 at Utica Ave. & Clarendon Rd

Crash Involving MTA Bus and Two Cars Injures 23

Police are investigating an accident in Brooklyn on Wednesday afternoon that injured 23 people, 3 of them critically, when a car was knocked into the path of an MTA bus.

Read More

Government Penalizes 721 Hospitals for High Rates of Infections, Injuries

Medicare is reducing payments to 721 hospitals, one out of every seven hospitals in the nation, for having high rates of “hospital-acquired” conditions (HAC.

Read More

Long Island Car Crash Kills 1 Person, Injures 2 More

Long Island Car Crash Kills 1 Person, Injures 2 More

A car accident on LI left one person dead & two more critically injured. The crash occurred Monday in Deer Park on Straight Path, south of Sagamore Lane.

Read More

FDA Gives 7 Companies Go Ahead To Market Generic Plavix

The U.S. Food & Drug Administration (FDA) just gave seven companies the go-ahead to market generic Plavix. Plavix is a blood thinner prescribed for the prevention of blood clots, heart attacks, and which has been linked to serious side effects such as the heart attacks and strokes it is supposed to ...

Read More

Decision on Pradaxa Bleeding Lawsuit Multidistrict Litigation Expected Soon

Victims of alleged Pradaxa injuries are awaiting word on whether their lawsuits will be consolidated in a multidistrict litigation. According to a report from The Madison Record, so far just over two dozen Pradaxa bleeding lawsuits have been filed in federal courts throughout the U.S.

Read More

Be Careful When Shopping for Toys This Holiday Season

beware-of-dangerous-toys-holiday-shoppers

Consumer experts warn shoppers to be aware this holiday season of dangerous toys that are still on store shelves and which are putting children at risk of injury. The U.S. Public Interest Research Group (PIRG) found that hazardous toys are … Continue reading

Posted in Children's Toys, Consumer Fraud, Defective Products, Health Concerns |

FDA Deems Hospira Recall of its GemStar Infusion System a Class I

hospira-recall-class-one-infushion-pumps

The U.S. Food and Drug Administration (FDA) just announced a Class I recall of Hospira Inc.’s GemStar Infusion System, over a pressure sensor calibration drift. The FDA’s Class I recall designation means that the situation is one in which there … Continue reading

Posted in Defective Medical Devices, Defective Products |

FDA Reviewing Efficacy of “Morning After Pill” in Women Weighing Over 165 Pounds

morning-after-pill-effectiveness

United States health regulators just announced that they are reviewing the efficacy of Plan B emergency contraceptive pills as they may not offer the same benefits in women who weigh more than 165 pounds. In the U.S., the Plan B … Continue reading

Posted in Health Concerns, Pharmaceuticals |

LG TVs Spying on Consumers

lg-smart-tv-spying-on-customers

Recently, the maker of LG Electronics’ Smart TV admitted to collecting information on consumers’ viewing habits, apparently without consumer knowledge. LG’s new line of Smart TVs collect viewer data to customize the advertising seen on their screens, according to Law … Continue reading

Posted in Consumer Fraud |

Mental Health Risks Tied to Steroid Injections Meant to Stop Premature Birth

steroid-injections-before-birth-mental-health-problems

A new study reveals that steroid injections used to prevent premature birth might increase future risks of behavioral and emotional problems in the developing children. Expectant mothers who might give birth prematurely are often treated with an infusion of glucocorticoids. … Continue reading

Posted in Health Concerns, Pharmaceuticals |

FDA Orders Genetic Testing Firm to Cease DNA Analysis Service Sales

dna-testing-halted-by-fda

The U.S. Food and Drug Administration (FDA) has demanded 23andMe, a DNA testing service, to immediately stop selling and marketing its services until the agency gives the firm clearance to do so. The FDA is seeking to stop the sales … Continue reading

Posted in Defective Medical Devices, Defective Products, Health Concerns, Pharmaceuticals |

FDA Issues Drug Safety Statement Over Meridian Medical Technologies Auto-Injectors

meridian-duo-dote-injector-extended-expire-date

The U.S. Food and Drug Administration (FDA) just announced that it has been made aware of a supply disruption of auto injectors for Atropen (atropine),
DuoDote (atropine/pralidoxime chloride),
morphine sulfate,
pralidoxime chloride, and 
diazepam. The auto injectors involved are manufactured by Meridian Medical … Continue reading

Posted in Pharmaceuticals |

Diabetes Drug-Pancreatitis Link Supported in Another Study

mimetic-diabtes-linked-to-pancreatitis

Another study has made a connection between Type 2 diabetes drugs known as incretin mimetics and increased rates of developing pancreatitis, a known precursor to pancreatic cancer. Incretin mimetics, are GLP-1-based diabetes therapies and include Byetta and Bydureon (exenatide); Victoza … Continue reading

Posted in Byetta Cancer, Pharmaceuticals |

Amgen’s Aranesp Claims Get FDA Attention for Overstating Benefits, Minimizing Risks

aranesp-anemia-drug-misleading-claims

The U.S. Food and Drug Administration (FDA) just wrote to drug maker, Amgen Inc., about misleading marketing claims concerning its anemia drug, Aranesp (darbepoetin alfa). The letter, not quite as serious as an agency warning letter, scolded the drug maker … Continue reading

Posted in Pharmaceuticals |

Cameras Catching Nursing Home Abuse Lead to Controversy

cameras-monitor-nursing-home-abuse

Nursing home abuse is among the most devastating of horrors targeting our older, vulnerable loved ones. Recently, a case in which a small camera—meant to catch a petty thief—caught a loved one being abused and taunted, increasing awareness of both … Continue reading

Posted in Legal News, Nursing Home Abuse |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.